英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
Trimethoprim EP Impurity I (E-Isomer) |
甲氧芐啶EP雜質(zhì)I |
118791-61-0 |
詳細(xì)
|
Allopurinol Impurity 1 |
別嘌醇雜質(zhì)H |
41621-10-7 |
詳細(xì)
|
Allopurinol Impurity 2 |
6-甲基-1氫-吡唑并[3,4-D]嘧啶-4(5H氫)酮 |
30129-57-8 |
詳細(xì)
|
Metronidazole EP Impurity C |
甲硝唑雜質(zhì)C |
5006-69-9 |
詳細(xì)
|
Metronidazole EP Impurity E |
異甲硝唑 |
705-19-1 |
詳細(xì)
|
Metronidazole EP Impurity F |
O-羥乙基甲硝唑 |
16156-94-8 |
詳細(xì)
|
Azilsartan Impurity 25 |
阿齊沙坦雜質(zhì)5 |
183986-69-8 |
詳細(xì)
|
Azilsartan Impurity 26 |
阿齊沙坦雜質(zhì) 10 |
139481-40-6 |
詳細(xì)
|
Azilsartan Impurity 27 |
1-[(2'-(羥基脒基)[1,1-聯(lián)苯基]-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯 |
147403-65-4 |
詳細(xì)
|
Azilsartan Impurity 29 |
|
147404-12-4 |
詳細(xì)
|
Azilsartan Impurity 30 |
阿齊沙坦雜質(zhì)N |
2244031-86-3 |
詳細(xì)
|
Azilsartan Impurity 31 |
美阿沙坦鉀雜質(zhì)8 |
1993494-84-0 |
詳細(xì)
|
Azilsartan Impurity 36 |
1-[(2'-氰基聯(lián)苯-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯 |
139481-44-0 |
詳細(xì)
|
Azilsartan Impurity 40 |
阿齊沙坦雜質(zhì)15 |
147403-35-8 |
詳細(xì)
|
Glimepiride Impurity 1 |
格列美脲雜質(zhì)6 |
247098-17-5 |
詳細(xì)
|
Sorafenib EP Impurity A |
4-(4-氨基苯氧基)-N-甲基-2-吡啶甲酰胺 |
284462-37-9 |
詳細(xì)
|
Sorafenib EP Impurity D |
Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
2206827-14-5 |
詳細(xì)
|
Oseltamivir impurity 39 |
奧司他韋雜質(zhì)B(2-疊氮雜質(zhì)) |
2125702-80-7 |
詳細(xì)
|
Oseltamivir impurity 41 |
(1R,5S,6R)-Ethyl 5-(Pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate |
2413185-89-2 |
詳細(xì)
|
Oseltamivir impurity 43 |
奧司他韋雜質(zhì)17 |
2413185-88-1 |
詳細(xì)
|
Oseltamivir impurity 49 |
(3R,4S,5R)-4,5-二羥基-3-(戊烷-3-羥基)環(huán)己-1-烯-1-羧酸乙酯 |
2097777-49-4 |
詳細(xì)
|
Oseltamivir impurity 52 |
|
28547-24-2 |
詳細(xì)
|
Oseltamivir impurity 53 |
|
1070663-96-5 |
詳細(xì)
|
Olaparib Impurity 3 |
(3-氧代-1,3-二氫異苯并呋喃-1-基)膦酸二甲酯 |
61260-15-9 |
詳細(xì)
|
Olaparib Impurity 4 |
5-[(3.4-二氫-4-氧代-1-酞嗪基)甲基]-2-氟苯腈 |
1021298-68-9 |
詳細(xì)
|
Olaparib Impurity 6 |
2-氟-5-溴苯腈 |
179897-89-3 |
詳細(xì)
|
Olaparib Impurity 7 |
N-BOC-哌嗪 |
57260-71-6 |
詳細(xì)
|
Olaparib Impurity 8 |
環(huán)丙甲酸 |
1759-53-1 |
詳細(xì)
|
Olaparib Impurity 9 |
4-(環(huán)丙烷羰基)哌嗪-1-羧酸叔丁酯 |
414910-15-9 |
詳細(xì)
|
Olaparib Impurity 10 |
哌嗪二鹽酸鹽 |
142-64-3 |
詳細(xì)
|
Olaparib Impurity 11 |
奧拉帕尼雜質(zhì) |
763114-04-1 |
詳細(xì)
|
Olaparib Impurity 12 |
1-[5-[(3,4-二氫-4-氧代-1-酞嗪基)甲基]-2-氟苯甲?;鵠哌嗪 |
763111-47-3 |
詳細(xì)
|
Olaparib Impurity 13 |
Olaparib Impurity 15 |
2250243-17-3 |
詳細(xì)
|
Olaparib Impurity 14 |
亞磷酸二甲酯 |
868-85-9 |
詳細(xì)
|
Olaparib Impurity 15 |
1,1,3,3-四甲基脲 |
632-22-4 |
詳細(xì)
|
Olaparib Impurity 16 |
N-羥基-7-氮雜苯并三氮唑 |
39968-33-7 |
詳細(xì)
|
Butylphthalide Impurity 3 |
1(3H)-Isobenzofuranone, 5-bromo-3-hydroxy- |
102126-71-6 |
詳細(xì)
|
Butylphthalide Impurity 4 |
丁苯酞雜質(zhì)18 |
503822-00-2 |
詳細(xì)
|
Butylphthalide Impurity 5 |
6-溴-3-羥基異苯并呋喃-1(3氫)-酮 |
1225206-60-9 |
詳細(xì)
|
Butylphthalide Impurity 6 |
丁苯酞雜質(zhì)27 |
1225206-61-0 |
詳細(xì)
|
Butylphthalide Impurity 7 |
3,6-二溴異苯并呋喃-1(3H)-酮 |
40125-50-6 |
詳細(xì)
|
Butylphthalide Impurity 8 |
3,5-DIBROMO-1,3-DIHYDRO-2-BENZOFURAN-1-ONE |
102126-70-5 |
詳細(xì)
|
Butylphthalide Impurity 9 |
3-butyl-5-bromo-1(3H)-isobenzofuranone |
950681-35-3 |
詳細(xì)
|
Phloroglucinol Impurity 1 |
2,4,6-三甲氧基甲苯 |
14107-97-2 |
詳細(xì)
|
Phloroglucinol Impurity 72 |
Benzene, 1,3,5-trimethoxy-2-(methylthio)- |
154389-62-5 |
詳細(xì)
|
Phloroglucinol Impurity 73 |
2,4,6,3',5'-PENTAMETHOXYBIPHENYL |
84212-55-5 |
詳細(xì)
|
Valsartan Impurity 5 |
纈沙坦雜質(zhì)Ⅱ |
1111177-30-0 |
詳細(xì)
|
Azilsartan Medoxomil |
阿奇沙坦酯 |
863031-21-4 |
詳細(xì)
|
Azilsartan Medoxomil Potassium Salt |
阿齊沙坦酯衍生物 |
863031-24-7 |
詳細(xì)
|
Azilsartan Impurity 18 |
阿齊沙坦雜質(zhì) (F) |
147404-75-9 |
詳細(xì)
|
Azilsartan Impurity 19 |
坎地沙坦酯中間體 |
139481-41-7 |
詳細(xì)
|
Azilsartan Impurity 21 |
阿齊沙坦雜質(zhì) |
632322-61-3 |
詳細(xì)
|
Paliperidone Impurity 4 |
5-氟-3-(4-哌啶基)-1,2-苯并異噁唑鹽酸鹽 |
84163-64-4 |
詳細(xì)
|
Butylphthalide Impurity 1 |
2-戊?;郊姿?/td>
| 550-37-8 |
詳細(xì)
|
Butylphthalide Impurity 2 |
丁苯酞雜質(zhì) |
199736-94-2 |
詳細(xì)
|
Olaparib Impurity 18 |
5-[(3,4-二氫-4-氧代-1-酞嗪基)甲基]-苯甲酸 |
420846-72-6 |
詳細(xì)
|
Olaparib Impurity 19 |
奧拉帕利雜質(zhì)31 |
458535-34-7 |
詳細(xì)
|
Olaparib Impurity 20 |
環(huán)丙基甲酰氯 |
4023-34-1 |
詳細(xì)
|
Olaparib Impurity 21 |
5-[(3,4-二氫-4-氧代-1-酞嗪基)甲基]-2-氟苯甲酸 |
763114-26-7 |
詳細(xì)
|
Olaparib Impurity 22 |
3-氰基苯甲醛 |
24964-64-5 |
詳細(xì)
|
Olaparib Impurity 23 |
3-羥基異苯并呋喃-1(3H)-酮 |
16859-59-9 |
詳細(xì)
|
Olaparib Impurity 24 |
2-氟-5-甲?;诫?/td>
| 218301-22-5 |
詳細(xì)
|
Olaparib Impurity 25 |
1-環(huán)丙甲?;哙?/td>
| 59878-57-8 |
詳細(xì)
|
Olaparib Impurity 26 |
3-溴苯酞 |
6940-49-4 |
詳細(xì)
|
Olaparib Impurity 28 |
4-氰基-2-氟苯酸 |
164149-28-4 |
詳細(xì)
|
Erythromycin EP Impurity M |
Erythromycin EP Impurity M |
616234-56-1 |
詳細(xì)
|
Diclofenac EP Impurity E |
2-吲哚酮 |
59-48-3 |
詳細(xì)
|
Doxofylline Impurity 7 |
多索茶堿雜質(zhì)7 |
|
詳細(xì)
|
Doxofylline Impurity 10 |
多索茶堿雜質(zhì)02 |
180262-60-6 |
詳細(xì)
|
Doxofylline Impurity 12 |
羥丙茶堿 |
603-00-9 |
詳細(xì)
|
Doxofylline Impurity 13 |
茶堿雜質(zhì)23 |
23146-07-8 |
詳細(xì)
|
Nedaplatin impurity 2 |
奈達(dá)鉑雜質(zhì)4 |
20115-64-4 |
詳細(xì)
|
Nedaplatin impurity 3 |
奈達(dá)鉑雜質(zhì)5 |
103436-60-8 |
詳細(xì)
|
Mesalazine EP Impurity S |
美沙拉嗪EP雜質(zhì)S |
1797983-23-3 |
詳細(xì)
|
Tryptophan EP Impurity A |
粉色E |
132685-02-0 |
詳細(xì)
|
Tryptophan EP Impurity B |
色氨酸雜質(zhì)B(非對(duì)映體的混合物) |
184955-21-3 |
詳細(xì)
|
Tryptophan EP Impurity C |
L-犬尿氨酸 |
2922-83-0 |
詳細(xì)
|
Tryptophan EP Impurity D |
5-羥基-L-色氨酸 |
4350-09-8 |
詳細(xì)
|
Tryptophan EP Impurity E |
N'-甲酰基-L-尿嘧啶 |
3978-11-8 |
詳細(xì)
|
Tryptophan EP Impurity F |
色氨酸雜質(zhì) |
145545-23-9 |
詳細(xì)
|
Olaparib Impurity 17 |
2-氟-5-醛基苯甲酸 |
550363-85-4 |
詳細(xì)
|
Tryptophan EP Impurity H |
2,3,4,9-四氫-1H-beta-咔啉-3-甲酸 |
6052-68-2 |
詳細(xì)
|
Tryptophan EP Impurity I |
1 - 甲基-2,3,4,9 - 四氫-1H-Β-咔啉-3 - 羧酸鹽DATA |
5470-37-1 |
詳細(xì)
|
Tryptophan EP Impurity J |
Tryptophan Impurity 3 |
164068-19-3 |
詳細(xì)
|
Tryptophan EP Impurity K |
L-色氨酸EP雜質(zhì)K |
149724-31-2 |
詳細(xì)
|
Tryptophan EP Impurity L |
色氨酸EP雜質(zhì)E |
287170-99-4 |
詳細(xì)
|
Tryptophan Impurity 1 |
色氨酸EP雜質(zhì)G |
236094-74-9 |
詳細(xì)
|
Tryptophan Impurity 2 |
DL-2,3-二氫-2-氧雜色氨酸 |
32999-55-6 |
詳細(xì)
|
Tofacitinib Impurity 17 |
托法替尼雜質(zhì) |
2459302-77-1 |
詳細(xì)
|
Tofacitinib Impurity 22 |
Tofacitinib Impurity 29 |
1638499-35-0 |
詳細(xì)
|
Tofacitinib Impurity 23 |
托法替尼雜質(zhì)166 |
1638499-36-1 |
詳細(xì)
|
Afatinib Impurity 4 |
N-(3-氯-4-氟苯基)-7-甲氧基-6-硝基喹唑啉-4-胺 |
179552-74-0 |
詳細(xì)
|
Afatinib Impurity 5 |
Afatinib Impurity JXH |
2223677-60-7 |
詳細(xì)
|
Afatinib Impurity 6 |
阿法替尼雜質(zhì)18 |
2413212-25-4 |
詳細(xì)
|
Afatinib Impurity 7 |
4-氯-7-氟-6-硝基喹唑啉 |
162012-70-6 |
詳細(xì)
|
Afatinib Impurity 9 |
阿法替尼中間體 |
314771-88-5 |
詳細(xì)
|
Afatinib Impurity 11 |
P-[2-[[4-[(3-氯-4-氟苯基)氨基]-7-[[(3S)-四氫-3-呋喃基]氧基-6-喹唑啉基]氨基]-2-氧代乙基]膦酸二乙酯 |
618061-76-0 |
詳細(xì)
|
Afatinib Impurity 13 |
4-Hydroxy 4-Dedimethylamino Afatinib |
2121530-37-6 |
詳細(xì)
|
Afatinib Impurity 14 |
Afatinib IMpurity SF |
2223677-62-9 |
詳細(xì)
|
Afatinib Impurity 15 |
Afatinib IMpurity SCl |
2223677-63-0 |
詳細(xì)
|